The Charts of Tandem Diabetes Are Probably Headed Higher With This Subtle Clue

The market potential for TNDM is even greater worldwide.

Bausch Health Is Struggling to Go Sideways - Risk of Being Long

Let's review the charts and indicators of BHC.

AbbVie: The Right Mixture for the Perfect Stock

ABBV has a positive earnings-per-share growth, an expanding price-to-earnings multiple and dividends that could result in annual shareholder returns well above 20%.

NovoCure Looks Due for a Technical Correction

Let's look at the charts and indicators in addition to following the fundamentals.

Despite a Good Quarter the Charts of Intuitive Surgical Look Vulnerable

Let's check out the charts and indicators.

Hologic Looks Good as Long as the Stock Doesn't Close Below This Key Level

Let's check out the charts and indicators of this medical equipment maker.

Swinging for the Small-Cap Biotech Fences Requires Accepting Strikeouts

Striking out is painful, but is not as impactful as missing out on the next potential home run because you're still brooding about whiffing on your last investment.

Exact Sciences Is Poised to Test New Highs on the Charts

Here's how to trade the stock right now.

Pfizer Deal Might Be Good Treatment for Mylan

But this off-patent tie-up comes with some questions -- such as why are so many Mylan executives hanging on?

Jim Cramer: Running Down the BTF vs. WTF Scoreboard

That's Better Than Feared vs. Worse Than Feared when it comes to these companies' latest reports on a big day for earnings.